Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

The global pharmaceutical market has been hit by the weight-loss drug Wigobi ... studies analyzing large-scale medical data had consistently suggested that Wigobi could be effective in treating ...

They stated that they aim to treat not only weight loss but also cardiovascular ... Novo Nordisk, which leads the market with the obesity drug Wigobi, is also developing a follow-up obesity medication ...